Coya Therapeutics (COYA) provided a status update of its investigational regulatory T cell-derived exosome platform intended for the treatment ...

EVast Bio’s proprietary exosome-based platform extends far beyond osteoarthritis, offering a vehicle for advanced drug delivery across multiple therapeutic areas. By leveraging the natural ...

Compared with synthetic nanoparticles and mammalian cell derived exosomes (MDEs), PELNs have lower toxicity and immunogenicity and possess excellent biocompatibility. The intrinsic properties of PELNs ...

The biotin-linked antibodies utilized included Anti-CD9 (Thermo Fisher, no. 13-0098-82), anti-CD63 (Biolegend, no. 353018), and anti-CD81 (Biolegend, no. 349514). Total exosome isolation reagent (for ...

Exosomes are double-membrane vesicular nanoparticles in the category of extracellular vesicles, ranging in size from 30 to 150 nm, and are released from cells through a specific multi-step exocytosis ...

What’s exciting about exosomes today is how they’re being used after aesthetic procedures. Skincare has come a long way in recent years—from basic moisturizers to high-tech treatments that tap into ...

Exosomes, a class of small extracellular vesicles, can transfer biological information (e.g., proteins, nucleic acids, and metabolites as messengers) from secreting cells to target recipient cells, ...